Peter Amanatides serves as Executive at GENEREX BIOTECHNOLOGY CORP, where they oversee executive responsibilities. Since joining the company, Peter Amanatides has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 30, 2006 involved receiving (via award) 150,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 30, 2006 | GNBT | $0 | Award | 150,000 | $N/A | Discretionary |
Peter Amanatides currently holds 151,000 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Amanatides has been a net neutral trader of GNBT stock. They have purchased $0 and sold $0 worth of shares.
Peter Amanatides's most recent insider trade was on May 30, 2006, when they sold 150,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted